The centre has given 100 per cent advance to two of India's Covid vaccine manufacturers till July, senior sources in the Finance Ministry told NDTV on Monday night. The advance - calculated as ₹ 3,000 crore for the Serum Institute (which produces Covishield) and ₹ 1,500 crore for Bharat Biotech (which produces Covaxin) will ensure the two manufacturers get the funding necessary to continue, and scale up, production of vaccines, the sources said.
from Videos https://ift.tt/3tAwEe7
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment